Skip to main content
. Author manuscript; available in PMC: 2015 Mar 15.
Published in final edited form as: Eur J Pharmacol. 2014 Jan 28;0:125–129. doi: 10.1016/j.ejphar.2014.01.032

Fig. 1.

Fig. 1

MDMA or methamphetamine (MA) exposure can adversely affect the balance between metabolic and immune systems and contribute to CNS damage and neuropsychiatric impairments (e.g., cognitive deficits, depression, and anxiety) (e.g., Parrott, 2006). The question mark in the figure indicates that there are questions yet to be answered regarding how drug-induced changes in energy regulation affect immune function (and vice versa).